Evidence-Based Benefits
- Sleep quality — Bent et al. (2006) meta-analyzed 16 eligible studies and concluded valerian improved subjective sleep quality compared to placebo, though objective measures (polysomnography) showed inconsistent results, suggesting the benefit is primarily perceived sleep quality
- GABA modulation — valerenic acid acts as a positive allosteric modulator of GABA-A receptors (specifically the beta-3 subunit), similar in mechanism to benzodiazepines but with a much gentler effect profile and no dependence risk
- Anxiety reduction — Andreatini et al. (2002) conducted a pilot RCT comparing valerian to diazepam for generalized anxiety disorder and found comparable anxiolytic effects, though the study was small and requires replication
- Sleep onset latency — Leathwood et al. (1982) showed 450mg aqueous valerian extract significantly reduced self-reported sleep onset time compared to placebo in a crossover study
- No morning impairment — unlike benzodiazepines and Z-drugs, valerian does not impair morning alertness, reaction time, or concentration at standard doses, making it safer for daily use